Yiyao Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yiyao Technology - overview
Established
2018
Location
Beijing, -, China
Primary Industry
Pharmaceuticals
About
Established in 2018 and based in Beijing, China, Yiyao Technology operates as a Technology is a pharmaceutical company that focuses on developing medicine via utilizing artificial intelligence technology. As of 2022, the company raised financial from Powercloud, and Innovation Angel Funds. The company's AI systems can be categorized into Deep Learning based Efficacy Prediction System (DLEPS), Ligand Ensembles based Small Molecules’ Design, Intelligent Docking System driven by Reinforcement Learning, and Retrosynthesis Prediction System for Natural Products. DLEPS can be used to find novel targets for diseases by finding the compound first, then studying their MOA.
The overall accuracy of DLEPS at the animal level is around 60%.
Current Investors
Powercloud, Innoangel Fund, Sangel Capital
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.gigaceuticals.com
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.